David Hagin

10.1k total citations
64 papers, 1.3k citations indexed

About

David Hagin is a scholar working on Immunology, Infectious Diseases and Oncology. According to data from OpenAlex, David Hagin has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 15 papers in Infectious Diseases and 12 papers in Oncology. Recurrent topics in David Hagin's work include Immune Cell Function and Interaction (19 papers), T-cell and B-cell Immunology (16 papers) and Immunodeficiency and Autoimmune Disorders (13 papers). David Hagin is often cited by papers focused on Immune Cell Function and Interaction (19 papers), T-cell and B-cell Immunology (16 papers) and Immunodeficiency and Autoimmune Disorders (13 papers). David Hagin collaborates with scholars based in Israel, United States and Germany. David Hagin's co-authors include Yaīr Reisner, Maria Paola Martelli, Troy R. Torgerson, Hans D. Ochs, Tal Freund, Shira Benor, Iram Khan, Andrew M. Scharenberg, Karen Sommer and Nicholas Hubbard and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of Allergy and Clinical Immunology.

In The Last Decade

David Hagin

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Hagin Israel	21	679	327	305	262	255	64	1.3k
Srdjan Pašić Serbia	14	869 1.3×	155 0.5×	135 0.4×	264 1.0×	154 0.6×	25	1.2k
Marco Chiarini Italy	19	502 0.7×	145 0.4×	260 0.9×	120 0.5×	170 0.7×	61	1.0k
Kathrin Rieger Germany	16	448 0.7×	282 0.9×	215 0.7×	116 0.4×	518 2.0×	32	1.4k
Emily S.J. Edwards Australia	15	628 0.9×	264 0.8×	282 0.9×	132 0.5×	65 0.3×	37	993
Marco Marziali Italy	24	589 0.9×	148 0.5×	249 0.8×	151 0.6×	363 1.4×	49	1.5k
Ellen G. van Lochem Netherlands	16	490 0.7×	201 0.6×	110 0.4×	207 0.8×	178 0.7×	27	1.1k
Ludvig A. Munthe Norway	22	937 1.4×	482 1.5×	461 1.5×	139 0.5×	567 2.2×	76	2.4k
Jennifer Hodge United States	11	384 0.6×	223 0.7×	87 0.3×	158 0.6×	226 0.9×	15	1.1k
Smita Y. Patel United Kingdom	20	784 1.2×	114 0.3×	185 0.6×	269 1.0×	150 0.6×	46	1.3k
Junichi Sugita Japan	25	677 1.0×	465 1.4×	109 0.4×	117 0.4×	750 2.9×	117	1.8k

Countries citing papers authored by David Hagin

Since Specialization

Citations

This map shows the geographic impact of David Hagin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hagin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hagin more than expected).

Fields of papers citing papers by David Hagin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hagin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hagin. The network helps show where David Hagin may publish in the future.

Co-authorship network of co-authors of David Hagin

This figure shows the co-authorship network connecting the top 25 collaborators of David Hagin. A scholar is included among the top collaborators of David Hagin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hagin. David Hagin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Konen, Franz Felix, Torsten Witte, Diana Ernst, et al.. (2025). Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis. Neurological Research and Practice. 7(1). 48–48.

Konen, Franz Felix, Nora Möhn, Torsten Witte, et al.. (2025). Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders. Autoimmunity Reviews. 24(4). 103754–103754.

Eviatar, Tali, et al.. (2024). Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls. Clinical & Experimental Immunology. 217(2). 167–172. 1 indexed citations

Tamir, Hadas, Michael Mor, David Hagin, et al.. (2023). Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens. iScience. 26(2). 105957–105957. 28 indexed citations

Hagin, David, Tal Freund, Tamar Halperin, et al.. (2023). Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: A Prospective Cohort Study. Open Forum Infectious Diseases. 10(8). ofad347–ofad347. 3 indexed citations

Konen, Franz Felix, Nora Möhn, Torsten Witte, et al.. (2023). Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders. Autoimmunity Reviews. 22(5). 103312–103312. 32 indexed citations

Ram, Ron, Tal Freund, Tami Halperin, et al.. (2022). Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy—A Single Center Prospective Cohort Study. Transplantation and Cellular Therapy. 28(5). 278.e1–278.e4. 7 indexed citations

Saiag, Esther, Ayelet Grupper, Irit Avivi, et al.. (2022). The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients. Clinical Microbiology and Infection. 28(5). 735.e5–735.e8. 15 indexed citations

Shamriz, Oded, Limor Rubin, Anthony Simon, et al.. (2022). Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience. Frontiers in Immunology. 13. 1044933–1044933. 4 indexed citations

10.

Ram, Ron, David Hagin, Tal Freund, et al.. (2021). Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study. Transplantation and Cellular Therapy. 27(9). 788–794. 94 indexed citations

11.

Hagin, David, Tal Freund, Tami Halperin, et al.. (2021). Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity. Journal of Allergy and Clinical Immunology. 148(3). 739–749. 116 indexed citations

12.

Luttwak, Efrat, David Hagin, Chava Perry, et al.. (2020). Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease—a single center case series. Bone Marrow Transplantation. 56(5). 1031–1037. 27 indexed citations

13.

Chermesh, Irit, Lael Werner, Ortal Barel, et al.. (2020). Monogenic Inflammatory Bowel Disease: It's Never Too Late to Make a Diagnosis. Frontiers in Immunology. 11. 1775–1775. 6 indexed citations

14.

Gambineri, Eleonora, Sara Ciullini Mannurita, David Hagin, et al.. (2018). Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome. Frontiers in Immunology. 9. 2411–2411. 120 indexed citations

15.

Hagin, David, Yacov Shacham, Shmuel Kivity, & Shira Benor. (2018). Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm. The Journal of Allergy and Clinical Immunology In Practice. 7(3). 1076–1077. 4 indexed citations

16.

Sullivan, Kathleen E., Hamid Bassiri, Ahmed Aziz Bousfiha, et al.. (2017). Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies. Journal of Clinical Immunology. 37(7). 650–692. 5 indexed citations

17.

Hagin, David, Lauri M. Burroughs, & Troy R. Torgerson. (2015). Hematopoietic Stem Cell Transplant for Immune Deficiency and Immune Dysregulation Disorders. Immunology and Allergy Clinics of North America. 35(4). 695–711. 11 indexed citations

18.

Hagin, David, Meirav Ingbir, Ran Reshef, et al.. (2006). Differential regulation of L-arginine transporters (cationic amino acid transporter-1 and -2) by peroxynitrite in rat mesangial cells. Nephrology Dialysis Transplantation. 21(12). 3409–3414. 8 indexed citations

19.

Solomon, A & David Hagin. (2004). The effect of the growth hormone on the axial elongation of rat eyes. Investigative Ophthalmology & Visual Science. 45(13). 1242–1242.

20.

Dougherty, Edward J. & David Hagin. (1989). The future looks bright for cardiac catheterization.. PubMed. 7(1). 1, 14–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact